Energy Fuels (TSE:EFR) reported a second-quarter net loss of $33.6 million as transaction and development spending weighed on results, while its uranium business generated $25 million in revenue, approximately $14 million in gross profit and a 57% gross margin. President and Chief Executive Officer
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Urban Edge Properties (NYSE:UE) reported second-quarter results that exceeded its internal expectations, driven by higher leasing spreads, same-property net operating income growth and contributions from redevelopment activity. The retail real estate investment trust raised its full-year funds from
Westinghouse is a hidden asset for Cameco.
Uranium prices hit decade highs as nuclear demand accelerates globally.
Lightbridge (NASDAQ:LTBR) reported progress in its nuclear fuel development program during the second quarter and first half of 2026, including the removal of its first irradiated fuel material samples from Idaho National Laboratory’s Advanced Test Reactor and steps toward commercial-scale fabricati
Despite a year-over-year earnings dip, Cameco Corp (CCJ) leverages decade-high uranium prices, a robust contract portfolio, and a growing AP1000 pipeline to position for sustained growth.
Cameco (NYSE:CCJ) said its 2026 annual plan remains intact as it navigates temporary operational disruptions at its Saskatchewan uranium assets and sees strengthening conditions in long-term uranium contracting and nuclear-power development. Chief Executive Officer Tim Gitzel said the company is on
Cameco (CCJ) delivered earnings and revenue surprises of -50.00% and +10.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Investing.com -- Cameco Corp. (TSX: CCO; NYSE: CCJ) reported second quarter results that beat revenue expectations but fell short on earnings, with shares rising 3.3% premarket following the announcement.
Why Cameco’s latest earnings matter for investors Cameco (TSX:CCO) has drawn fresh attention after reporting first quarter 2026 earnings and operating results, reaffirming full year guidance and highlighting strong interest in its nuclear technology and services. See our latest analysis for Cameco. Cameco’s share price is CA$156.24 after a modest pullback in the last week and quarter. However, its year to date share price return of 15.43% and one year total shareholder return of 136.15% point...
Cameco (NYSE:CCJ) executives said first-quarter 2026 results were in line with the company’s annual plan and reiterated full-year guidance, while offering extensive commentary on the outlook for nuclear power, uranium contracting, and growth opportunities tied to Westinghouse’s AP1000 reactor techno
Nuclear stocks Cameco and BWX Technologies both traded near buy points on Tuesday morning after reporting better-than-expected first-quarter earnings. Cameco is the "sole vertically integrated nuclear company," from uranium mining and refining to providing the reactor core via its 49% stake in Westinghouse Electric, William Blair analyst Jed Dorsheimer wrote in an April 20 coverage initiation. BWX is the U.S. Navy's main nuclear reactor supplier though its recent growth is being fueled by its commercial business.
Cameco (CCJ) delivered earnings and revenue surprises of +18.26% and +24.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Ameresco (AMRC) delivered earnings and revenue surprises of -22.22% and +10.27%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Lightbridge (NASDAQ:LTBR) used its first-quarter 2026 business update to highlight progress in intellectual property protection, fuel development and testing partnerships, and expanded internal engineering capabilities, alongside an increase in quarterly losses tied largely to higher research spendi
Centrus Energy heads into Q1 earnings with falling EPS estimates, rising uranium prices and delayed shipments that could shift margins and revenues.